'Build a big portfolio': Wealth manager shares strategies for investing in the market
Hennion & Walsh Asset Management president Kevin Mahn breaks down the factors propelling a recent stock rally in biotech and highlights investing opportunities on 'Making Money.'
This is a 'potentially practice-changing' drug, senior biotech analyst predicts
Needham & Company managing director Gil Blum analyzes which companies have a 'higher chance of success' in the biotech sector on 'Making Money.'
Chinese genomics company rejects human rights abuses after US blacklists its units
The U.S. Commerce Department has added three units of Chinese company BGI Group to its "entity list" over allegations of contributions to Chinese surveillance.
Complaint letter filed with SEC regarding Natera’s promotion of prenatal screening technology
A complaint to the SEC alleges that Natera misled investors and others about its prenatal screening product.